28 March 2008 /Side effects and trials
Since the beginning of the year, the US Food and Drug Administration (FDA) has recorded an increasing number of reported adverse drug reactions - some 800 reports, of which 19 involved deaths in patients - from the use of heparin.
27 March 2008 /Side effects and trials
New reports have shown that the sclerosis medicine Tysabrin® (natalizumab) may cause liver injury. Sclerosis patients who receive Tysabri® are therefore urged to see their doctor if they develop symptoms of liver problems.
18 March 2008 /Product information
The Danish Medicines Agency has been made aware that the Health Sciences Authority in Singapore has confiscated large quantities of the illegal medicinal product Power 1 Walnut, which has been marketed as a potency-enhancing product containing only herbs.
17 March 2008 /Side effects and trials
Follow-up on previous announcements. In the spring of 2006, the Danish Medicines Agency initiated an investigation by the EU Pharmacovigilance Working Party of the safety of gadolinium-containing MRI contrast mediums in kidney patients.
05 March 2008 /Side effects and trials
The Danish Medicines Agency has decided to suspend the marketing authorisation for the medicinal product Somadril® with effect from 2 June 2008.